Intracranial malignant lymphomas: clinicopathological study of 26 autopsy cases
- PMID: 10532421
- DOI: 10.1007/BF02478899
Intracranial malignant lymphomas: clinicopathological study of 26 autopsy cases
Abstract
We examined 26 autopsy-proven cases of intracranial malignant lymphoma (IML) in immunocompetent patients to determine the extent of neoplastic involvement of the central nervous system (CNS) and to evaluate the effects of radiation on the tumor and brain tissue. All tumors were identified as diffuse non-Hodgkin's lymphomas of B-cell origin. In six patients who had not received radiotherapy, the clinical course of the disease was short and extensive infiltration of the tumor was seen. The remaining 20 patients were treated with radiotherapy and had a longer survival time. Leptomeningeal involvement was common, but extensive subarachnoid proliferation of the tumor was seen in only two cases. The posterior, but not anterior, lobe of the pituitary was involved in 5 of 22 cases, and choroid plexus involvement was seen in 4 of 21. Direct invasion of the tumor into the spinal cord, which tended to occur in patients with posterior fossa masses, was observed in 5 of 21 cases. Following irradiation, coagulation necrosis was frequently found in the invading zone as well as in the tumor mass, and degeneration of the white matter was also seen. We suggest that IML can extensively infiltrate into the CNS, including the posterior lobe of the pituitary and spinal cord, and that radiation injury to the brain appears to occur relatively easily in this disease.
Similar articles
-
Involvement of the central nervous system in malignant lymphomas.Virchows Arch A Pathol Anat Histol. 1976 Jul 21;370(4):345-62. doi: 10.1007/BF00445779. Virchows Arch A Pathol Anat Histol. 1976. PMID: 826017
-
Sites of origin of primary intracerebral malignant lymphoma.Neurosurgery. 1989 Jul;25(1):14-9. doi: 10.1097/00006123-198907000-00003. Neurosurgery. 1989. PMID: 2755572
-
Central nervous system complications by malignant lymphomas: radiation schedule and treatment results.Int J Radiat Oncol Biol Phys. 1986 Feb;12(2):197-202. doi: 10.1016/0360-3016(86)90094-5. Int J Radiat Oncol Biol Phys. 1986. PMID: 3949570
-
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.Neurology. 2004 Feb 10;62(3):451-6. doi: 10.1212/01.wnl.0000106941.51340.a2. Neurology. 2004. PMID: 14872029 Review.
-
[Malignant primary non-Hodgkin's lymphoma of the central nervous system. Anatomo-clinical analysis of 35 cases].Ann Pathol. 1990;10(4):268-74. Ann Pathol. 1990. PMID: 2257025 Review. French.
Cited by
-
Pituitary stalk thickening and primary central nervous system lymphoma.J Neurooncol. 2004 Mar-Apr;67(1-2):227-31. doi: 10.1023/b:neon.0000021863.06620.48. J Neurooncol. 2004. PMID: 15072472
-
MRI findings of primary CNS lymphoma in 26 immunocompetent patients.Korean J Radiol. 2010 May-Jun;11(3):269-77. doi: 10.3348/kjr.2010.11.3.269. Epub 2010 Apr 29. Korean J Radiol. 2010. PMID: 20461180 Free PMC article.
-
Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.CNS Oncol. 2014 Jan;3(1):77-85. doi: 10.2217/cns.13.63. CNS Oncol. 2014. PMID: 25054902 Free PMC article. Review.
-
Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL.Cancers (Basel). 2021 May 28;13(11):2665. doi: 10.3390/cancers13112665. Cancers (Basel). 2021. PMID: 34071407 Free PMC article. Review.
-
Primary Pituitary Lymphoma in Immunocompetent Patients: A Report on Two Case Studies and the Review of Literature.Front Endocrinol (Lausanne). 2021 Feb 4;11:562850. doi: 10.3389/fendo.2020.562850. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33613443 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical